Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03755518 |
|---|---|
| Brief Title: | A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib (FREEDOM) |
| First Submitted : | November 8, 2018 |
| First Submitted that Met QC Criteria : | November 26, 2018 |
| First Posted : | November 28, 2018 |
| Results First Submitted : | November 22, 2022 |
| Results First Posted with QC Comments : | December 20, 2022 |
| Results First Submitted that Met QC Criteria : | February 13, 2023 |
| Results First Posted : | March 9, 2023 |
| Last Update Submitted that Met QC Criteria : | February 13, 2023 |
| Last Update Posted : | March 9, 2023 |